Cargando…
Meta-analysis of predictive models to assess the clinical validity and utility for patient-centered medical decision making: application to the CAncer of the Prostate Risk Assessment (CAPRA)
BACKGROUND: The Cancer of the Prostate Risk Assessment (CAPRA) score was designed and validated several times to predict the biochemical recurrence-free survival after a radical prostatectomy. Our objectives were, first, to study the clinical validity of the CAPRA score, and, second, to assess its c...
Autores principales: | Lorent, Marine, Maalmi, Haïfa, Tessier, Philippe, Supiot, Stéphane, Dantan, Etienne, Foucher, Yohann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323757/ https://www.ncbi.nlm.nih.gov/pubmed/30616621 http://dx.doi.org/10.1186/s12911-018-0727-2 |
Ejemplares similares
-
A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients
por: Foucher, Yohann, et al.
Publicado: (2018) -
Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): Ability to Predict Cancer Progression and Decision-Making Regarding Adjuvant Therapy after Radical Prostatectomy
por: Seo, Won Ik, et al.
Publicado: (2014) -
Integrating Geriatric Assessment into Decision-Making after Prostatectomy: Adjuvant Radiotherapy, Salvage Radiotherapy, or None?
por: Goineau, Aurore, et al.
Publicado: (2015) -
Methodological quality of multivariate prognostic models for intracranial haemorrhages in intensive care units: a systematic review
por: Simon-Pimmel, Jeanne, et al.
Publicado: (2021) -
Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?
por: Nowroozi, Mohamadreza, et al.
Publicado: (2016)